George L. Drusano
About
George L. Drusano is a scholar working on Pharmacology, Epidemiology and Molecular Medicine.
According to data from OpenAlex, George L. Drusano has authored 371 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Pharmacology, 160 papers in Epidemiology and 144 papers in Molecular Medicine. Recurrent topics in George L. Drusano's work include Antibiotics Pharmacokinetics and Efficacy (225 papers), Antibiotic Resistance in Bacteria (144 papers) and Pneumonia and Respiratory Infections (84 papers). George L. Drusano is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (225 papers), Antibiotic Resistance in Bacteria (144 papers) and Pneumonia and Respiratory Infections (84 papers). George L. Drusano collaborates with scholars based in United States, United Kingdom and Germany. George L. Drusano's co-authors include Arnold Louie, Thomas P. Lodise, Ben M. Lomaestro, Weiguo Liu, Harold C. Standiford, Paul G. Ambrose, Sujata M. Bhavnani, Tawanda Gumbo, Keith A. Rodvold and Sandra L. Preston and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
In The Last Decade
George L. Drusano
368 papers receiving 19.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| George L. Drusano United States | 71 | 12.4k | 7.9k | 7.2k | 6.8k | 3.0k | 371 | 20.2k | ||
| Alan Forrest United States | 63 | 7.8k 0.6× | 4.7k 0.6× | 6.3k 0.9× | 3.7k 0.6× | 2.4k 0.8× | 298 | 15.4k | ||
| Matteo Bassetti Italy | 73 | 5.2k 0.4× | 7.3k 0.9× | 7.0k 1.0× | 6.8k 1.0× | 2.7k 0.9× | 574 | 19.5k | ||
| David P. Nicolau United States | 61 | 11.6k 0.9× | 7.4k 0.9× | 9.9k 1.4× | 3.5k 0.5× | 2.5k 0.8× | 739 | 18.7k | ||
| David C. Hooper United States | 78 | 7.0k 0.6× | 4.8k 0.6× | 12.8k 1.8× | 5.3k 0.8× | 2.5k 0.8× | 274 | 24.2k | ||
| John Turnidge Australia | 71 | 6.0k 0.5× | 5.8k 0.7× | 7.1k 1.0× | 6.3k 0.9× | 3.5k 1.1× | 264 | 17.3k | ||
| William A. Craig United States | 68 | 11.4k 0.9× | 6.3k 0.8× | 6.6k 0.9× | 5.0k 0.7× | 3.4k 1.1× | 183 | 18.0k | ||
| Gunnar Kahlmeter Sweden | 54 | 3.5k 0.3× | 6.3k 0.8× | 10.7k 1.5× | 4.4k 0.7× | 3.7k 1.2× | 204 | 21.4k | ||
| Pierluigi Viale Italy | 49 | 3.2k 0.3× | 3.7k 0.5× | 3.3k 0.5× | 3.4k 0.5× | 1.3k 0.4× | 419 | 10.1k | ||
| Louis B. Rice United States | 58 | 4.3k 0.3× | 6.1k 0.8× | 13.3k 1.9× | 8.0k 1.2× | 4.8k 1.6× | 176 | 27.3k | ||
| Johan W. Mouton Netherlands | 71 | 7.3k 0.6× | 8.1k 1.0× | 5.5k 0.8× | 6.1k 0.9× | 2.0k 0.7× | 353 | 18.6k |
Countries citing papers authored by George L. Drusano
Since
Specialization
Citations
This map shows the geographic impact of George L. Drusano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George L. Drusano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George L. Drusano more than expected).
Fields of papers citing papers by George L. Drusano
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by George L. Drusano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George L. Drusano. The network helps show where George L. Drusano may publish in the future.
Co-authorship network of co-authors of George L. Drusano
This figure shows the co-authorship network connecting the top 25 collaborators of George L. Drusano. A scholar is included among the top collaborators of George L. Drusano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George L. Drusano. George L. Drusano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Heine, Henry S., Bret K. Purcell, A. R. Chase, et al.. (2024). Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant Burkholderia pseudomallei in a murine infection model. Antimicrobial Agents and Chemotherapy. 69(1). e0129524–e0129524.
2.
Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2023). Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model. Frontiers in Pharmacology. 14. 1291885–1291885.
3.
Drusano, George L., et al.. (2023). Inoculum-Based Dosing: A Novel Concept for Combining Time with Concentration-Dependent Antibiotics to Optimize Clinical and Microbiological Outcomes in Severe Gram Negative Sepsis. Antibiotics. 12(11). 1581–1581.
4.
Kim, Sarah, Arnold Louie, George L. Drusano, et al.. (2021). Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid. International Journal of Antimicrobial Agents. 59(2). 106509–106509.
5.
Kim, Tae Hwan, Xun Tao, Bartolomé Moyá, et al.. (2020). Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-ResistantKlebsiella pneumoniaeandEnterobacter cloacae. mBio. 11(1).
6.
Jiao, Yuanyuan, Bartolomé Moyá, Alexandre Prehn Zavascki, et al.. (2019). Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial Agents and Chemotherapy. 63(7).
7.
Roberts, Jason A., Mohd H. Abdul‐Aziz, Jeffrey Lipman, et al.. (2014). Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. The Lancet Infectious Diseases. 14(6). 498–509.
8.
Louie, Arnold, et al.. (2010). The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression. Antimicrobial Agents and Chemotherapy. 54(6). 2646–2654.
9.
Louie, Arnold, Henry S. Heine, Kiho Kim, et al.. (2008). Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 52(7). 2486–2496.
10.
Lodise, Thomas P., Ben M. Lomaestro, Jeffrey Graves, & George L. Drusano. (2008). Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity. Antimicrobial Agents and Chemotherapy. 52(4). 1330–1336.
11.
Sakka, Samir G., Jürgen B. Bulitta, Martina Kinzig‐Schippers, et al.. (2007). Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial. Antimicrobial Agents and Chemotherapy. 51(9). 3304–3310.
12.
Gumbo, Tawanda, Arnold Louie, Mark R. Deziel, et al.. (2007). Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin. Antimicrobial Agents and Chemotherapy. 51(11). 3781–3788.
13.
Louie, Arnold, David Brown, Weiguo Liu, et al.. (2007). In Vitro Infection Model Characterizing the Effect of Efflux Pump Inhibition on Prevention of Resistance to Levofloxacin and Ciprofloxacin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 51(11). 3988–4000.
14.
Lodise, Thomas P., Ben M. Lomaestro, & George L. Drusano. (2006). Application of Antimicrobial Pharmacodynamic Concepts into Clinical Practice: Focus on β‐Lactam Antibiotics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(9). 1320–1332.
15.
Louie, Arnold, Mark R. Deziel, Weiguo Liu, et al.. (2005). Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity. Antimicrobial Agents and Chemotherapy. 49(12). 5058–5068.
16.
Hope, William, Peter Warn, Joanne Sharp, et al.. (2005). Surface Response Modeling to Examine the Combination of Amphotericin B Deoxycholate and 5‐Fluorocytosine for Treatment of Invasive Candidiasis. The Journal of Infectious Diseases. 192(4). 673–680.
17.
Drusano, George L., Brian M. Sadler, Judith Millard, et al.. (1997). Pharmacodynamics of 141W94 as determined by short term change in HIV RNA Influence of viral isolate baseline EC50. 37. 4.
18.
Drusano, George L., et al.. (1996). Mechanisms of efflux for fluoroquinolone antibiotics from the vitreous humor of rabbits. Investigative Ophthalmology & Visual Science. 37(3).
19.
Drusano, George L., et al.. (1994). Optimal Sampling Theory: Effect of Error in a Nominal Parameter Value on Bias and Precision of Parameter Estimation. The Journal of Clinical Pharmacology. 34(10). 967–974.
20.
Schwalbe, Ruth A., et al.. (1991). Characterization of enterococcal strains exhibiting a novel glycopeptide susceptibility pattern. 91. 20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alan Forrest Breakdown of academic impact, for papers by Matteo Bassetti Breakdown of academic impact, for papers by David P. Nicolau Breakdown of academic impact, for papers by David C. Hooper Breakdown of academic impact, for papers by John Turnidge Breakdown of academic impact, for papers by William A. Craig Breakdown of academic impact, for papers by Gunnar Kahlmeter Breakdown of academic impact, for papers by Pierluigi Viale Breakdown of academic impact, for papers by Louis B. Rice Breakdown of academic impact, for papers by Johan W. Mouton